{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Boston&page=7&state=Massachusetts", "query": { "state": "Massachusetts", "city": "Boston", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 21461, "total_pages": 2147, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Boston&page=8&state=Massachusetts&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Boston&page=6&state=Massachusetts&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-03T11:14:44.072Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00048165", "title": "A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Heart Transplantation" ], "interventions": [ { "name": "Daclizumab", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Mycophenolate mofetil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "cyclosporine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 434, "start_date": "1999-08", "completion_date": "2002-08", "has_results": true, "last_update_posted_date": "2016-06-13", "last_synced_at": "2026-11-03T11:14:44.072Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Los Angeles, California • Tampa, Florida + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00048165" }, { "nct_id": "NCT01201967", "title": "A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Depression", "Generalized Anxiety Disorder", "Panic Disorder" ], "interventions": [ { "name": "Collaborative care", "type": "OTHER" }, { "name": "Usual care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 183, "start_date": "2010-09", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2014-09-25", "last_synced_at": "2026-11-03T11:14:44.072Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01201967" }, { "nct_id": "NCT02094300", "title": "Zenith® Dissection Endovascular System", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aortic Dissection" ], "interventions": [ { "name": "Zenith® Dissection Endovascular Graft", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Cook Group Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2007-12", "completion_date": "2016-11", "has_results": true, "last_update_posted_date": "2017-02-06", "last_synced_at": "2026-11-03T11:14:44.072Z", "location_count": 5, "location_summary": "Gainesville, Florida • Boston, Massachusetts • Camden, New Jersey + 2 more", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Camden", "state": "New Jersey" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Philadephia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02094300" }, { "nct_id": "NCT03012100", "title": "Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bilateral Breast Carcinoma", "Breast Inflammatory Carcinoma", "Stage IB Breast Cancer AJCC v7", "Stage II Breast Cancer AJCC v6 and v7", "Stage IIA Breast Cancer AJCC v6 and v7", "Stage IIB Breast Cancer AJCC v6 and v7", "Stage III Breast Cancer AJCC v7", "Stage IIIA Breast Cancer AJCC v7", "Stage IIIB Breast Cancer AJCC v7", "Stage IIIC Breast Cancer AJCC v7", "Triple-Negative Breast Carcinoma", "Unilateral Breast Carcinoma" ], "interventions": [ { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Multi-epitope Folate Receptor Alpha Peptide Vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo Administration", "type": "OTHER" }, { "name": "Sargramostim", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "OTHER", "BIOLOGICAL" ], "sponsor": "Academic and Community Cancer Research United", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 280, "start_date": "2017-03-31", "completion_date": "2026-07-31", "has_results": true, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-11-03T11:14:44.072Z", "location_count": 12, "location_summary": "Scottsdale, Arizona • Duarte, California • Jacksonville, Florida + 8 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03012100" }, { "nct_id": "NCT02031536", "title": "Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gastrinoma", "Glucagonoma", "Insulinoma", "Liver Metastases", "Pancreatic Polypeptide Tumor", "Recurrent Islet Cell Carcinoma", "Somatostatinoma" ], "interventions": [ { "name": "everolimus", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "ECOG-ACRIN Cancer Research Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2014-04-10", "completion_date": "2017-07-19", "has_results": true, "last_update_posted_date": "2023-06-29", "last_synced_at": "2026-11-03T11:14:44.072Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02031536" }, { "nct_id": "NCT04103164", "title": "Pilot Study to Evaluate the Effect of Multiple Passes on Port Wine Stain Treatments With the Cutera Excel V™ Laser.", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Port-Wine Stain" ], "interventions": [ { "name": "Cutera excel V™ Laser", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 10, "start_date": "2020-01-15", "completion_date": "2020-07-15", "has_results": false, "last_update_posted_date": "2019-10-15", "last_synced_at": "2026-11-03T11:14:44.072Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04103164" }, { "nct_id": "NCT03775031", "title": "Chemical Peels and Fractional Laser on IGF-1 Levels in Skin", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Skin Cancer" ], "interventions": [ { "name": "Fractional Laser and Chemical Peel", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 20, "start_date": "2019-12-01", "completion_date": "2021-07-01", "has_results": false, "last_update_posted_date": "2020-10-22", "last_synced_at": "2026-11-03T11:14:44.072Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03775031" }, { "nct_id": "NCT06557772", "title": "A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coeliac Disease", "Celiac Disease" ], "interventions": [ { "name": "Amlitelimab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "SIGE", "type": "DIETARY_SUPPLEMENT" }, { "name": "Gluten-free product (GFP)", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 229, "start_date": "2024-08-29", "completion_date": "2029-04-10", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-11-03T11:14:44.072Z", "location_count": 35, "location_summary": "Scottsdale, Arizona • Arcadia, California • Lancaster, California + 32 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Arcadia", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Oxnard", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06557772" }, { "nct_id": "NCT05248295", "title": "Investigating the Effects of Rhythm and Entrainment on Fluency in People With Aphasia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aphasia", "Apraxia of Speech" ], "interventions": [ { "name": "Unison speech (vs. solo)", "type": "BEHAVIORAL" }, { "name": "Metrical timing (vs. conversational)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "MGH Institute of Health Professions", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 75, "start_date": "2018-12-04", "completion_date": "2023-06-28", "has_results": true, "last_update_posted_date": "2025-05-18", "last_synced_at": "2026-11-03T11:14:44.072Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05248295" }, { "nct_id": "NCT01073475", "title": "Maternal Newborn Health Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pregnancy Outcome Trends in Low-resource Geographic Areas" ], "interventions": [ { "name": "There is no intervention associated with the parent MNHR study. For the MNHR COVID sub-study, participants will be asked to provide a blood specimen at or near delivery.", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "NICHD Global Network for Women's and Children's Health", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 950000, "start_date": "2008-05", "completion_date": "2030-05", "has_results": false, "last_update_posted_date": "2026-01-21", "last_synced_at": "2026-11-03T11:14:44.072Z", "location_count": 8, "location_summary": "Birmingham, Alabama • Aurora, Colorado • Indianapolis, Indiana + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01073475" } ] }